Ncardia to exhibit and present at SLAS2019
Date: February 2-6
From February 2-6, more than 6,000 life sciences researchers and technologists will convene for SLAS2019. The Society for Laboratory Automation and Screening (SLAS) is a great opportunity to learn more about Automation and High-Throughput Technologies, Assay Development and Screening, and Cellular Technologies.
The Ncardia team will be pleased to welcome you at the Ncardia scientific session and to introduce you to our new products and services portfolio, as well as to discuss with you at our posters or at our booth.
Ncardia CEO Stefan Braam is delighted to be presenting his talk:
- “Induced pluripotent stem cell-based high throughput screening for modulators of
Session Title: Advanced in vitro Culture systems including Stem Cell-based Screening technologies
Date: Wednesday, February 6, 2019
Time: 09:30 am
Ncardia Booth # 1514
We are looking forward to meeting you. Stop by our booth to discover our screening services for cardiovascular and neuro drug discovery.
We are very proud to present/co-present posters at this conference.
- High throughput assessment of cardiotoxicity using bioreactor produced hiPSC-derived cardiomyocytes
- Poster ID: 1048-D
- Tuesday, February 5, 2019 5:00 PM – 6:00 PM
High throughput efficacy screen in diseased models of hypertrophy using hiPSC derived Cardiomyocytes
Simultaneous Measurement of Contractility, Electrophysiology, and Troponin I Secretion to Determine Cardiotoxicity in hiPSC-Derived Cardiomyocytes
Simultaneous Measurement of Contraction, Voltage and Calcium in hiPSC-CMs for the Detection of Inotropic Effects under Blinded Conditions
Controlled, large scale manufacturing of hiPSC-derived cardiomyocytes in stirred-tank bioreactors enabling high throughput phenotypic screening
Further poster information (IDs; date and times) to follow.